BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/9/2023 2:18:10 PM | Browse: 192 | Download: 321
 |
Received |
|
2023-06-08 06:01 |
|
Peer-Review Started |
|
2023-06-08 06:04 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-18 07:53 |
|
Revised |
|
2023-07-22 11:12 |
|
Second Decision |
|
2023-08-09 03:09 |
|
Accepted by Journal Editor-in-Chief |
|
2023-08-13 09:43 |
|
Accepted by Company Editor-in-Chief |
|
2023-08-17 02:26 |
|
Articles in Press |
|
2023-08-17 02:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-19 02:06 |
|
Publish the Manuscript Online |
|
2023-10-09 11:18 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chu Lin, Zong-Lin Li, Xiao-Ling Cai, Sui-Yuan Hu, Fang Lv, Wen-Jia Yang and Li-Nong Ji |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Natural Science Foundation |
7202216 |
| National Natural Science Foundation of China |
81970698 |
| National Natural Science Foundation of China |
81970708 |
|
| Corresponding Author |
Li-Nong Ji, MD, Professor, Department of Endocrinology and Metabolism, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China. jiln@bjmu.edu.cn |
| Key Words |
Chiglitazar; Thiazolidinedione; Glycemic control; β-cell function; Drug safety |
| Core Tip |
This is the first indirect meta-analysis comparing efficacy and safety of chiglitazar and thiazolidinediones (TZDs). In patients with type 2 diabetes, compared with TZDs, chiglitazar induced favorable glycemic and lipidemic control, preserved β-cell function, without increasing safety concerns. |
| Publish Date |
2023-10-09 11:18 |
| Citation |
Lin C, Li ZL, Cai XL, Hu SY, Lv F, Yang WJ, Ji LN. Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2023; 14(10): 1573-1584 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i10/1573.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i10.1573 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
